MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
基本信息
- 批准号:6101290
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:T cell receptor T lymphocyte antigen receptors biological signal transduction chimeric proteins clone cells enzyme activity enzyme structure gene expression intermolecular interaction leukocyte activation /transformation major histocompatibility complex phospholipase C phosphoproteins phosphorylation protein structure function receptor binding transfection
项目摘要
Perturbation of the T cell antigen receptor (TCR) by antigen/MHC or by
anti-receptor antibodies initiates a cascade of events which includes
protein tyrosine kinase activation and the phosphorylation and activation
of phospholipase Cgamma1 (PLCgamma1). The activation of PLCgamma1 is
critical in that PLCgamma1-mediated phosphoinositide (PI) hydrolysis
controls calcium mobilization and protein kinase C activation, two
obligatory events in lymphokine secretions and cell proliferation. The
objective of this project is to establish the mechanisms by which immune
receptors regulate PLCgamma1. PLCgamma1 includes two src-homology (SH)
2 domains that bind tyrosine-phosphorylated proteins and an SH3 domain
that interacts with proline-rich polipeptides. By acting as docking sites
for other molecules, these domains play a role in coupling proteins to
surface receptors or other regulatory molecules. Site-specific mutant
constructs of an epitope-tagged ectopically-expressed PLCgamma1 protein
were used to characterize structural requirements for PLCgamma1
activation, to identify proteins that interact with PLCgamma1 subdomains,
and dissect the individual role of these domains in PLCgamma1 activation.
These studies have shown that the amino terminal SH2 (SH2(N)) domain, but
not the carboxyl-terminal SH2 (SH2(C)) domain, was required and
sufficient for TCR-induced PLCgamma1 tyrosine phosphorylation. The
defective phosphorylation of the SH2(N) domain mutant was associated with
its inability to interact with a 36-38-kDa phosphoprotein. Further
structural/ functional characterization of PLCgamma1 was accomplished by
expressing wild type or mutant PLCgamma1 proteins in a PLCg-negative
chicken B cell line, P10-14. Similar to our previous findings in T
cells, the SH2(N) domain was required and sufficient for B cell receptor
(BCR)-induced PLCgamma1 tyrosine phosphorylation. The association of
PLCgamma1 with an 80-kDa tyrosine-phosphorylated protein was also
exclusively dependent upon an intact SH2(N) domain. TCR or BCR-induced
membrane translocation of PLCgamma1 required the SH2(N) domain, but was
also decreased by mutation of the SH3 domain. The addition of a
myristoylation signal to force membrane targeting of PLCgamma1 did not
bypass the SH2(N) domain requirement for phosphorylation. BCR-induced
PI hydrolysis was abrogated by mutation of either the SH2(N) or the
SH2(C) domain and was partially decreased by mutation of the SH3 domain.
BCR-induced activation of an NF-AT reporter gene in
PLCgamma1-reconstituted P10-14 cells, an indication of Ca2+ mobilization,
showed an absolute requirement for both the SH2(N) and SH2(C) domains,
but not the SH3 domain. These data suggest a model of Ag
receptor-induced PLCgamma1 activation whereby the SH2(N) domain is
required and sufficient for promoting the interaction with a tyrosine
kinase, while both the SH2(N) domain and the SH3 domain participate in
translocating PLCgamma1 to the membrane. Tyrosine phosphorylation and
membrane recruitment, however, are per se insufficient for the enzymatic
activation of PLCgamma1, which also needs a functional SH2(C) domain.
Future efforts will be directed at investigating the structural
requirement for PLCgamma1 regulation via activation by other surface
molecules (e.g., CD2, CD28) and their signaling cross-talk with the TCR.
抗原/MHC对T细胞抗原受体(TCR)的干扰
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E BONVINI其他文献
E BONVINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E BONVINI', 18)}}的其他基金
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLCR1 ACTIVATION
T淋巴细胞激活机制--PLCR1激活的调控
- 批准号:
2569028 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF G-PROTEINS IN THE CONTROL OF INOSITOL PHOSPHOLIPID HYDROLYSIS IN T-CELLS
G 蛋白在控制 T 细胞中肌醇磷脂水解中的作用
- 批准号:
3811105 - 财政年份:
- 资助金额:
-- - 项目类别:
SIGNAL TRANSDUCTION VIA THE T CELL RECEPTOR /CD3 COMPLEX
通过 T 细胞受体 /CD3 复合物进行信号转导
- 批准号:
3804896 - 财政年份:
- 资助金额:
-- - 项目类别:
ANALYSIS OF INOSITOL PHOSPHATE METABOLISM IN T LYMPHOCYTES BY HPLC
HPLC分析磷酸肌醇在T淋巴细胞中的代谢
- 批准号:
3811108 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
- 批准号:
6161348 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual